CDKV Holdings’s Johnson & Johnson JNJ Stock Holding History

CDKV Holdings’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$405K	Hold	1,597	–	–	0.32%	49
2026 Q1	$390K	Hold	1,597	–	–	0.34%	48
2025 Q4	$330K	Buy	+1,597	New	+$316K	0.28%	59

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CDKV Holdings's JNJ Position: Q2 2026 in Review

CDKV Holdings held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 1,597 shares worth $405K. The position accounts for 0.32% of the portfolio, ranked #49.

CDKV Holdings first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

CDKV Holdings held 1,597 shares of Johnson & Johnson worth $405K as of Q2 2026.
CDKV Holdings left its Johnson & Johnson share count unchanged in Q2 2026.
Johnson & Johnson made up 0.32% of CDKV Holdings's portfolio in Q2 2026, its #49 holding.
CDKV Holdings first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on CDKV Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.